FC
Fulcrum Capital’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.3M | Buy |
131,109
+4,842
| +4% | +$379K | 2.17% | 16 |
|
2025
Q1 | $9.15M | Buy |
126,267
+4,255
| +3% | +$308K | 2.03% | 17 |
|
2024
Q4 | $9.03M | Buy |
122,012
+4,107
| +3% | +$304K | 1.89% | 17 |
|
2024
Q3 | $7.78M | Buy |
117,905
+4,067
| +4% | +$268K | 1.69% | 23 |
|
2024
Q2 | $10.5M | Buy |
113,838
+267
| +0.2% | +$24.7K | 2.39% | 11 |
|
2024
Q1 | $10.9M | Buy |
113,571
+479
| +0.4% | +$45.8K | 2.58% | 11 |
|
2023
Q4 | $8.62M | Buy |
113,092
+19,096
| +20% | +$1.46M | 2.23% | 15 |
|
2023
Q3 | $6.51M | Buy |
93,996
+322
| +0.3% | +$22.3K | 1.89% | 18 |
|
2023
Q2 | $8.84M | Sell |
93,674
-3,069
| -3% | -$289K | 2.32% | 12 |
|
2023
Q1 | $8M | Buy |
96,743
+7,034
| +8% | +$582K | 2.15% | 14 |
|
2022
Q4 | $6.69M | Buy |
89,709
+6,439
| +8% | +$480K | 1.93% | 19 |
|
2022
Q3 | $6.88M | Sell |
83,270
-2,487
| -3% | -$206K | 2.04% | 19 |
|
2022
Q2 | $8.16M | Sell |
85,757
-1,212
| -1% | -$115K | 2.56% | 13 |
|
2022
Q1 | $10.2M | Buy |
86,969
+774
| +0.9% | +$91.1K | 2.74% | 11 |
|
2021
Q4 | $11.2M | Buy |
86,195
+1,039
| +1% | +$135K | 2.42% | 13 |
|
2021
Q3 | $9.64M | Buy |
85,156
+106
| +0.1% | +$12K | 2.31% | 11 |
|
2021
Q2 | $8.81M | Buy |
85,050
+2,300
| +3% | +$238K | 2.21% | 17 |
|
2021
Q1 | $6.92M | Buy |
82,750
+3,454
| +4% | +$289K | 1.98% | 22 |
|
2020
Q4 | $7.23M | Buy |
79,296
+3,749
| +5% | +$342K | 2.16% | 18 |
|
2020
Q3 | $6.03M | Sell |
75,547
-6,776
| -8% | -$541K | 2.18% | 25 |
|
2020
Q2 | $5.69M | Buy |
82,323
+53,395
| +185% | +$3.69M | 2.16% | 26 |
|
2020
Q1 | $5.46M | Buy |
28,928
+110
| +0.4% | +$20.7K | 2.48% | 23 |
|
2019
Q4 | $6.72M | Buy |
28,818
+74
| +0.3% | +$17.3K | 2.08% | 20 |
|
2019
Q3 | $6.32M | Sell |
28,744
-27
| -0.1% | -$5.94K | 2.16% | 17 |
|
2019
Q2 | $5.32M | Buy |
28,771
+6,262
| +28% | +$1.16M | 1.95% | 26 |
|
2019
Q1 | $4.31M | Buy |
22,509
+665
| +3% | +$127K | 1.63% | 31 |
|
2018
Q4 | $3.35M | Buy |
21,844
+1,310
| +6% | +$201K | 1.51% | 32 |
|
2018
Q3 | $3.58M | Buy |
20,534
+476
| +2% | +$82.9K | 1.39% | 31 |
|
2018
Q2 | $2.92M | Buy |
+20,058
| New | +$2.92M | 1.39% | 28 |
|